Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases
Pamela Maher
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 3056-3056
Open Access | Times Cited: 193

Showing 1-25 of 193 citing articles:

Neuroprotective Effects of Quercetin in Alzheimer’s Disease
Haroon Khan, Hammad Ullah, Michael Aschner, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 59-59
Open Access | Times Cited: 379
The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
Syed Shams ul Hassan, Saptadip Samanta, Raju Dash, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 66
Evidence of Flavonoids on Disease Prevention
Meng Li, Mengqi Qian, Qian Jiang, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 527-527
Open Access | Times Cited: 57
Efficacy of virtual reality-based training programs and games on the improvement of cognitive disorders in patients: a systematic review and meta-analysis
Khadijeh Moulaei, Hamid Sharifi, Kambiz Bahaadinbeigy, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 34
New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach
Yanfei Liu, Weiliang Weng, Rui Gao, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-25
Open Access | Times Cited: 88
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
Shweta Devi, Vijay Kumar, Sandeep Kumar Singh, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 99-99
Open Access | Times Cited: 86
Control of Reactive Oxygen Species for the Prevention of Parkinson’s Disease: The Possible Application of Flavonoids
Tae Yeon Kim, Eunju Leem, Jae Man Lee, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 583-583
Open Access | Times Cited: 84
Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A Review of Human Studies
Snježana Petrović, Aleksandra Arsić, Danijela Ristić-Medić, et al.
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1128-1128
Open Access | Times Cited: 81
Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications
Efthalia Angelopoulou, Efstratios‐Stylianos Pyrgelis, Christina Piperi
Neurochemistry International (2019) Vol. 132, pp. 104612-104612
Closed Access | Times Cited: 75
Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
Priscila Baltazar Gonçalves, Ana Carolina Rennó Sodero, Yraima Cordeiro
Biomolecules (2021) Vol. 11, Iss. 5, pp. 767-767
Open Access | Times Cited: 70
Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid
Fanni Tóth, Edina Katalin Cseh, László Vécsei
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 403-403
Open Access | Times Cited: 69
ROS-Induced mtDNA Release: The Emerging Messenger for Communication between Neurons and Innate Immune Cells during Neurodegenerative Disorder Progression
Yuanxin Zhao, Buhan Liu, Long Xu, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 1917-1917
Open Access | Times Cited: 59
An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111906-111906
Open Access | Times Cited: 54
Identification and characterization of anthocyanins and non-anthocyanin phenolics from Australian native fruits and their antioxidant, antidiabetic, and anti-Alzheimer potential
Akhtar Ali, Jeremy J. Cottrell, Frank R. Dunshea
Food Research International (2022) Vol. 162, pp. 111951-111951
Open Access | Times Cited: 48
Therapeutic benefits of flavonoids against neuroinflammation: a systematic review
Hamsalakshmi, Ann Maria Alex, Mahalakshmi Arehally Marappa, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 111-136
Closed Access | Times Cited: 47
In Silico Molecular Docking Analysis of Karanjin against Alzheimer’s and Parkinson’s Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy
Charles Gnanaraj, Mahendran Sekar, Shivkanya Fuloria, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2834-2834
Open Access | Times Cited: 46
Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection
Osama Elsallabi, Antonia Patruno, Mirko Pesce, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 738-738
Open Access | Times Cited: 44
The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids
Leila Kooshki, Seyede Nazanin Zarneshan, Sajad Fakhri, et al.
Phytomedicine (2023) Vol. 112, pp. 154686-154686
Closed Access | Times Cited: 34
Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-κB Signaling Pathway
Maria Magdalena Barreca, Riccardo Alessandro, Chiara Corrado
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9236-9236
Open Access | Times Cited: 25
Pathogenesis of Neurodegenerative Diseases and the Protective Role of Natural Bioactive Components
Saptadip Samanta, Sanjoy Chakraborty, Debasis Bagchi
Journal of the American Nutrition Association (2023) Vol. 43, Iss. 1, pp. 20-32
Closed Access | Times Cited: 21
Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases
Stanley I.R. Okoduwa, Ibrahim Abdulwaliyu, Bernard E. Igiri, et al.
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100558-100558
Open Access | Times Cited: 10
Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Maria Tsekrekou, Maria Giannakou, Katerina Papanikolopoulou, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 8
The Neuroprotective Flavonoids Sterubin and Fisetin Maintain Mitochondrial Health under Oxytotic/Ferroptotic Stress and Improve Bioenergetic Efficiency in HT22 Neuronal Cells
Marie Goujon, Zhibin Liang, David Soriano‐Castell, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 460-460
Open Access | Times Cited: 7
Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives
Gagandeep Maan, Biplab Sikdar, Ashish Kumar, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 13, pp. 1169-1194
Closed Access | Times Cited: 65
Preventing and Treating Neurological Disorders with the Flavonol Fisetin
Pamela Maher
Brain Plasticity (2020) Vol. 6, Iss. 2, pp. 155-166
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top